# Alpha Lipoic Acid in Ulcerative Colitis

> **NCT06067698** · NA · RECRUITING · sponsor: **Tanta University** · enrollment: 60 (estimated)

## Conditions studied

- Ulcerative Colitis
- Ulcerative Colitis (UC)

## Interventions

- **DRUG:** "Mesalamine" and "alpha-lipoic acid"
- **DRUG:** "Mesalamine" and "Placebo"

## Key facts

- **NCT ID:** NCT06067698
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06067698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06067698, "Alpha Lipoic Acid in Ulcerative Colitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06067698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*